Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids).

Norrish G, Ding T, Field E, Ziólkowska L, Olivotto I, Limongelli G, Anastasakis A, Weintraub R, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Kubuš P, Daubeney PEF, Sarquella-Brugada G, Cesar S, Marrone C, Bhole V, Medrano C, Uzun O, Brown E, Gran F, Castro FJ, Stuart G, Vignati G, Barriales-Villa R, Guereta LG, Adwani S, Linter K, Bharucha T, Garcia-Pavia P, Rasmussen TB, Calcagnino MM, Jones CB, De Wilde H, Toru-Kubo J, Felice T, Mogensen J, Mathur S, Reinhardt Z, O'Mahony C, Elliott PM, Omar RZ, Kaski JP.

JAMA Cardiol. 2019 Aug 14. doi: 10.1001/jamacardio.2019.2861. [Epub ahead of print]

PMID:
31411652
2.

Effects of exercise training in heart failure with preserved ejection fraction: an updated systematic literature review.

Leggio M, Fusco A, Loreti C, Limongelli G, Bendini MG, Mazza A, Coraci D, Padua L.

Heart Fail Rev. 2019 Aug 9. doi: 10.1007/s10741-019-09841-x. [Epub ahead of print] Review.

PMID:
31399956
3.

Clinical and Genetic Findings in Children with Neurofibromatosis Type 1, Legius Syndrome, and Other Related Neurocutaneous Disorders.

Giugliano T, Santoro C, Torella A, Del Vecchio Blanco F, Grandone A, Onore ME, Melone MAB, Straccia G, Melis D, Piccolo V, Limongelli G, Buono S, Perrotta S, Nigro V, Piluso G.

Genes (Basel). 2019 Jul 31;10(8). pii: E580. doi: 10.3390/genes10080580.

4.

Exercise Capacity Characterization and Physical Activity Intensification Should Be Priorities in Heart Failure Patients.

Leggio M, Tiberti C, Armeni M, Limongelli G, Mazza A.

J Am Coll Cardiol. 2019 Jul 30;74(4):589-590. doi: 10.1016/j.jacc.2019.03.530. No abstract available.

PMID:
31345435
5.

Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy.

Limongelli G, Monda E, Tramonte S, Gragnano F, Masarone D, Frisso G, Esposito A, Gravino R, Ammendola E, Salerno G, Rubino M, Caiazza M, Russo M, Calabrò P, Elliott PM, Pacileo G.

Int J Cardiol. 2019 Jul 4. pii: S0167-5273(19)30883-6. doi: 10.1016/j.ijcard.2019.06.073. [Epub ahead of print]

PMID:
31303393
6.

Physical Activity and Fitness in Heart Failure With Preserved Ejection Fraction: Ready for Prime Time?

Leggio M, Tiberti C, Armeni M, Limongelli G, Mazza A.

JACC Heart Fail. 2019 Jul;7(7):633-634. doi: 10.1016/j.jchf.2019.03.017. No abstract available.

PMID:
31248575
7.

Beta Blockers Up-Titration in Patients with Heart Failure Reduced Ejection Fraction and Cardiac Resynchronization Therapy, a Single Center Study.

Masarone D, Verrengia M, Ammendola E, Gravino R, Valente F, Vastarella R, Rubino M, Limongelli G, Pacileo G.

Med Sci (Basel). 2019 Jun 18;7(6). pii: E71. doi: 10.3390/medsci7060071.

8.

Transradial access versus transfemoral access: a comparison of outcomes and efficacy in reducing hemorrhagic events.

Cesaro A, Moscarella E, Gragnano F, Perrotta R, Diana V, Pariggiano I, Concilio C, Alfieri A, Cesaro F, Mercone G, Falato S, Esposito A, Di Girolamo D, Limongelli G, Calabrò P.

Expert Rev Cardiovasc Ther. 2019 Jun;17(6):435-447. doi: 10.1080/14779072.2019.1627873.

PMID:
31213156
9.

The Importance of Baseline Physical Activity Level in Heart Failure With Preserved Ejection Fraction.

Leggio M, Tiberti C, Armeni M, Limongelli G, Mazza A.

JACC Heart Fail. 2019 Jun;7(6):534-535. doi: 10.1016/j.jchf.2019.02.012. No abstract available.

PMID:
31146880
10.

The Effects of Dairy Consumption on Blood Pressure and Risk of Hypertension.

Leggio M, Tiberti C, Armeni M, Limongelli G, Mazza A.

Am J Med. 2019 May 17. pii: S0002-9343(19)30313-4. doi: 10.1016/j.amjmed.2019.03.028. [Epub ahead of print] No abstract available.

PMID:
31109629
11.

Left Atrial Volume during Stress Is Associated with Increased Risk of Arrhythmias in Patients with Hypertrophic Cardiomyopathy.

Limongelli G, Fioretti V, Di Maio M, Verrengia M, Rubino M, Gravino R, Masarone D, D'Andrea A, Ciampi Q, Picano E, Elliott P, Pacileo G.

J Cardiovasc Echogr. 2019 Jan-Mar;29(1):1-6. doi: 10.4103/jcecho.jcecho_45_18.

12.

Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology.

Seferović PM, Polovina M, Bauersachs J, Arad M, Gal TB, Lund LH, Felix SB, Arbustini E, Caforio ALP, Farmakis D, Filippatos GS, Gialafos E, Kanjuh V, Krljanac G, Limongelli G, Linhart A, Lyon AR, Maksimović R, Miličić D, Milinković I, Noutsias M, Oto A, Oto Ö, Pavlović SU, Piepoli MF, Ristić AD, Rosano GMC, Seggewiss H, Ašanin M, Seferović JP, Ruschitzka F, Čelutkiene J, Jaarsma T, Mueller C, Moura B, Hill L, Volterrani M, Lopatin Y, Metra M, Backs J, Mullens W, Chioncel O, de Boer RA, Anker S, Rapezzi C, Coats AJS, Tschöpe C.

Eur J Heart Fail. 2019 May;21(5):553-576. doi: 10.1002/ejhf.1461. Epub 2019 Apr 16.

PMID:
30989768
13.

Precision medicine for diabetes management and primary cardiovascular prevention.

Leggio M, Tiberti C, Armeni M, Limongelli G, Mazza A.

J Intern Med. 2019 Jul;286(1):112-114. doi: 10.1111/joim.12899. Epub 2019 Apr 8. No abstract available.

PMID:
30957916
14.

Impact of lipoprotein(a) levels on recurrent cardiovascular events in patients with premature coronary artery disease.

Gragnano F, Fimiani F, Di Maio M, Cesaro A, Limongelli G, Cattano D, Calabrò P.

Intern Emerg Med. 2019 Jun;14(4):621-625. doi: 10.1007/s11739-019-02082-8. Epub 2019 Mar 30. No abstract available.

PMID:
30929131
15.

Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk.

Cesaro A, Gragnano F, Fimiani F, Moscarella E, Diana V, Pariggiano I, Concilio C, Natale F, Limongelli G, Bossone E, Calabrò P.

Eur J Prev Cardiol. 2019 Mar 26:2047487319839179. doi: 10.1177/2047487319839179. [Epub ahead of print] No abstract available.

PMID:
30913901
16.

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A Contemporary Reappraisal.

Pelliccia F, Niccoli G, Gragnano F, Limongelli G, Moscarella E, Andò G, Esposito A, Stabile E, Ussia GP, Tarantini G, Gimeno JR, Elliott P, Calabrò P.

EuroIntervention. 2019 Mar 12. pii: EIJ-D-18-00959. doi: 10.4244/EIJ-D-18-00959. [Epub ahead of print]

17.

Natural history of pulmonary atresia: The ACHD clinic perspective.

Limongelli G, Di Salvo G.

Int J Cardiol. 2019 Apr 1;280:67-68. doi: 10.1016/j.ijcard.2019.01.057. Epub 2019 Jan 16. No abstract available.

PMID:
30674433
18.

Cardiorespiratory Fitness in Healthy People: A Step Forward to Primary Cardiovascular Health Promotion.

Leggio M, Tiberti C, Limongelli G, Mazza A.

Am J Med. 2019 May;132(5):e564. doi: 10.1016/j.amjmed.2018.12.018. Epub 2019 Jan 14. No abstract available.

PMID:
30654909
19.

Prescribing pattern of antihypertensive drugs in two European cohorts: a population-based database study.

Malo S, Rabanaque MJ, Orlando V, Limongelli G, Feja C, Aguilar-Palacio I, Lallana MJ, Russo V, Menditto E.

Expert Rev Pharmacoecon Outcomes Res. 2019 Aug;19(4):463-471. doi: 10.1080/14737167.2019.1567338. Epub 2019 Jan 29.

PMID:
30644761
20.

Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years.

Paolillo S, Veglia F, Salvioni E, Corrà U, Piepoli M, Lagioia R, Limongelli G, Sinagra G, Cattadori G, Scardovi AB, Metra M, Senni M, Bonomi A, Scrutinio D, Raimondo R, Emdin M, Magrì D, Parati G, Re F, Cicoira M, Minà C, Correale M, Frigerio M, Bussotti M, Battaia E, Guazzi M, Badagliacca R, Di Lenarda A, Maggioni A, Passino C, Sciomer S, Pacileo G, Mapelli M, Vignati C, Clemenza F, Binno S, Lombardi C, Filardi PP, Agostoni P; MECKI Score Research Group (see Appendix).

Eur J Heart Fail. 2019 Feb;21(2):208-217. doi: 10.1002/ejhf.1364. Epub 2019 Jan 11.

PMID:
30632680
21.

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?

Duro G, Zizzo C, Cammarata G, Burlina A, Burlina A, Polo G, Scalia S, Oliveri R, Sciarrino S, Francofonte D, Alessandro R, Pisani A, Palladino G, Napoletano R, Tenuta M, Masarone D, Limongelli G, Riccio E, Frustaci A, Chimenti C, Ferri C, Pieruzzi F, Pieroni M, Spada M, Castana C, Caserta M, Monte I, Rodolico MS, Feriozzi S, Battaglia Y, Amico L, Losi MA, Autore C, Lombardi M, Zoccali C, Testa A, Postorino M, Mignani R, Zachara E, Giordano A, Colomba P.

Int J Mol Sci. 2018 Nov 23;19(12). pii: E3726. doi: 10.3390/ijms19123726.

22.

Anti-inflammatory diet to reduce mortality: is it time for a precision medicine approach?

Leggio M, Fusco A, Villano A, Limongelli G, Mazza A.

J Intern Med. 2019 Apr;285(4):469-471. doi: 10.1111/joim.12851. Epub 2018 Nov 18. No abstract available.

PMID:
30450654
23.

Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologists.

Boffi L, Russo P, Limongelli G.

Ital J Pediatr. 2018 Nov 16;44(Suppl 2):122. doi: 10.1186/s13052-018-0560-3. Review.

24.

Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update.

Masarone D, Limongelli G, Ammendola E, Verrengia M, Gravino R, Pacileo G.

J Clin Med. 2018 Nov 10;7(11). pii: E436. doi: 10.3390/jcm7110436. Review.

25.

Sex-related differences in cardiomyopathies.

Pelliccia F, Limongelli G, Autore C, Gimeno-Blanes JR, Basso C, Elliott P.

Int J Cardiol. 2019 Jul 1;286:239-243. doi: 10.1016/j.ijcard.2018.10.091. Epub 2018 Oct 30.

PMID:
30409740
26.

Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis.

O'Mahony C, Akhtar MM, Anastasiou Z, Guttmann OP, Vriesendorp PA, Michels M, Magrì D, Autore C, Fernández A, Ochoa JP, Leong KMW, Varnava AM, Monserrat L, Anastasakis A, Garcia-Pavia P, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Omar RZ, Elliott PM.

Heart. 2019 Apr;105(8):623-631. doi: 10.1136/heartjnl-2018-313700. Epub 2018 Oct 26.

PMID:
30366935
27.

The challenge of cardiomyopathies and heart failure in pregnancy.

Limongelli G, Rubino M, Esposito A, Russo M, Pacileo G.

Curr Opin Obstet Gynecol. 2018 Dec;30(6):378-384. doi: 10.1097/GCO.0000000000000496. Review.

PMID:
30299317
28.

Treatments targeting inotropy.

Maack C, Eschenhagen T, Hamdani N, Heinzel FR, Lyon AR, Manstein DJ, Metzger J, Papp Z, Tocchetti CG, Yilmaz MB, Anker SD, Balligand JL, Bauersachs J, Brutsaert D, Carrier L, Chlopicki S, Cleland JG, de Boer RA, Dietl A, Fischmeister R, Harjola VP, Heymans S, Hilfiker-Kleiner D, Holzmeister J, de Keulenaer G, Limongelli G, Linke WA, Lund LH, Masip J, Metra M, Mueller C, Pieske B, Ponikowski P, Ristic A, Ruschitzka F, Seferovic PM, Skouri H, Zimmermann WH, Mebazaa A.

Eur Heart J. 2018 Oct 8. doi: 10.1093/eurheartj/ehy600. [Epub ahead of print]

PMID:
30295807
29.

Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation.

Campodonico J, Piepoli M, Clemenza F, Bonomi A, Paolillo S, Salvioni E, Corrà U, Binno S, Veglia F, Lagioia R, Sinagra G, Cattadori G, Scardovi AB, Metra M, Senni M, Scrutinio D, Raimondo R, Emdin M, Magrì D, Parati G, Re F, Cicoira M, Minà C, Limongelli G, Correale M, Frigerio M, Bussotti M, Perna E, Battaia E, Guazzi M, Badagliacca R, Di Lenarda A, Maggioni A, Passino C, Sciomer S, Pacileo G, Mapelli M, Vignati C, Lombardi C, Filardi PP, Agostoni P; MECKI Score Research Group.

Int J Cardiol. 2018 Dec 15;273:141-146. doi: 10.1016/j.ijcard.2018.08.012. Epub 2018 Aug 6.

PMID:
30098827
30.

Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy.

Magri D, Agostoni P, Sinagra G, Re F, Correale M, Limongelli G, Zachara E, Mastromarino V, Santolamazza C, Casenghi M, Pacileo G, Valente F, Morosin M, Musumeci B, Pagannone E, Maruotti A, Uguccioni M, Volpe M, Autore C.

Int J Cardiol. 2018 Nov 15;271:125-131. doi: 10.1016/j.ijcard.2018.04.019. Epub 2018 Aug 4.

PMID:
30087038
31.

The Right Heart International Network (RIGHT-NET): Rationale, Objectives, Methodology, and Clinical Implications.

Ferrara F, Gargani L, Armstrong WF, Agoston G, Cittadini A, Citro R, D'Alto M, D'Andrea A, Dellegrottaglie S, De Luca N, Di Salvo G, Ghio S, Grünig E, Guazzi M, Kasprzak JD, Kolias TJ, Kovacs G, Lancellotti P, La Gerche A, Limongelli G, Marra AM, Moreo A, Ostenfeld E, Pieri F, Pratali L, Rudski LG, Saggar R, Saggar R, Scalese M, Selton-Suty C, Serra W, Stanziola AA, Voilliot D, Vriz O, Naeije R, Bossone E.

Heart Fail Clin. 2018 Jul;14(3):443-465. doi: 10.1016/j.hfc.2018.03.010.

PMID:
29966641
32.

Mitochondrial disease: learning from Charlie's lesson, trying to cure, trying much more to care.

Limongelli G, Wahbi K.

Future Cardiol. 2018 Jul;14(4):273-276. doi: 10.2217/fca-2018-0001. Epub 2018 Jun 27. No abstract available.

PMID:
29947560
33.

Diagnostic Clues for the Diagnosis of Nonsarcomeric Hypertrophic Cardiomyopathy (Phenocopies): Amyloidosis, Fabry Disease, and Mitochondrial Disease.

Limongelli G, Masarone D, Verrengia M, Gravino R, Salerno G, Castelletti S, Rubino M, Marrazzo T, Pisani A, Cecchi F, Elliott PM, Pacileo G.

J Cardiovasc Echogr. 2018 Apr-Jun;28(2):120-123. doi: 10.4103/jcecho.jcecho_2_18.

34.

A common polymorphism in the SCN5A gene is associated with dilated cardiomyopathy.

Mazzaccara C, Limongelli G, Petretta M, Vastarella R, Pacileo G, Bonaduce D, Salvatore F, Frisso G.

J Cardiovasc Med (Hagerstown). 2018 Jul;19(7):344-350. doi: 10.2459/JCM.0000000000000670.

35.

Erratum to: Management of Bradyarrhythmias in Heart Failure: A Tailored Approach.

Masarone D, Ammendola E, Rago A, Gravino R, Salerno G, Rubino M, Marrazzo T, Molino A, Calabrò P, Pacileo G, Limongelli G.

Adv Exp Med Biol. 2018;1067:405-406. doi: 10.1007/5584_2018_198. No abstract available.

PMID:
29644575
36.

Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry.

Bossone E, Arcopinto M, Iacoviello M, Triggiani V, Cacciatore F, Maiello C, Limongelli G, Masarone D, Perticone F, Sciacqua A, Perrone-Filardi P, Mancini A, Volterrani M, Vriz O, Castello R, Passantino A, Campo M, Modesti PA, De Giorgi A, Monte I, Puzzo A, Ballotta A, Caliendo L, D'Assante R, Marra AM, Salzano A, Suzuki T, Cittadini A; TOSCA Investigators.

Intern Emerg Med. 2018 Aug;13(5):661-671. doi: 10.1007/s11739-018-1844-8. Epub 2018 Apr 4.

PMID:
29619769
37.

Data on cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results.

Calcagni G, Limongelli G, D'Ambrosio A, Gesualdo F, Digilio MC, Baban A, Albanese SB, Versacci P, De Luca E, Ferrero GB, Baldassarre G, Agnoletti G, Banaudi E, Marek J, Kaski JP, Tuo G, Russo MG, Pacileo G, Milanesi O, Messina D, Marasini M, Cairello F, Formigari R, Brighenti M, Dallapiccola B, Tartaglia M, Marino B.

Data Brief. 2017 Dec 2;16:649-654. doi: 10.1016/j.dib.2017.11.085. eCollection 2018 Feb.

38.

On the Road from Gene to Therapy in Inherited Cardiomyopathies.

Limongelli G, Bossone E, Elliott PM, Day SM.

Heart Fail Clin. 2018 Apr;14(2):xi-xv. doi: 10.1016/j.hfc.2018.01.003. No abstract available.

PMID:
29525651
39.

Epidemiology and Clinical Aspects of Genetic Cardiomyopathies.

Masarone D, Kaski JP, Pacileo G, Elliott PM, Bossone E, Day SM, Limongelli G.

Heart Fail Clin. 2018 Apr;14(2):119-128. doi: 10.1016/j.hfc.2017.12.007. Review.

PMID:
29525641
40.

Common presentation of rare diseases: Aortic aneurysms & valves.

Arbustini E, Favalli V, Di Toro A, Giuliani L, Limongelli G.

Int J Cardiol. 2018 Apr 15;257:358-365. doi: 10.1016/j.ijcard.2018.01.003. Review.

PMID:
29506732
41.

Metabolically Healthy Obese and Cardiovascular Diseases: A Phenotype Misunderstanding.

Leggio M, Sgorbini L, Limongelli G.

J Am Coll Cardiol. 2018 Feb 20;71(7):813-814. doi: 10.1016/j.jacc.2017.10.108. No abstract available.

42.

Mineralocorticoid receptor antagonists for heart failure: a real-life observational study.

Bruno N, Sinagra G, Paolillo S, Bonomi A, Corrà U, Piepoli M, Veglia F, Salvioni E, Lagioia R, Metra M, Limongelli G, Cattadori G, Scardovi AB, Carubelli V, Scrutino D, Badagliacca R, Guazzi M, Raimondo R, Gentile P, Magrì D, Correale M, Parati G, Re F, Cicoira M, Frigerio M, Bussotti M, Vignati C, Oliva F, Mezzani A, Vergaro G, Di Lenarda A, Passino C, Sciomer S, Pacileo G, Ricci R, Contini M, Apostolo A, Palermo P, Mapelli M, Carriere C, Clemenza F, Binno S, Belardinelli R, Lombardi C, Perrone Filardi P, Emdin M, Agostoni P.

ESC Heart Fail. 2018 Jun;5(3):267-274. doi: 10.1002/ehf2.12244. Epub 2018 Feb 4.

43.

Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience.

Sperlongano S, Gragnano F, Natale F, D'Erasmo L, Concilio C, Cesaro A, Golia E, Crisci M, Sperlongano R, Fimiani F, Russo M, Arca M, Limongelli G, Calabrò P.

J Cardiovasc Med (Hagerstown). 2018 Mar;19(3):83-90. doi: 10.2459/JCM.0000000000000620.

PMID:
29389816
44.

Management of Arrhythmias in Heart Failure.

Masarone D, Limongelli G, Rubino M, Valente F, Vastarella R, Ammendola E, Gravino R, Verrengia M, Salerno G, Pacileo G.

J Cardiovasc Dev Dis. 2017 Feb 28;4(1). pii: E3. doi: 10.3390/jcdd4010003. Review.

45.

Pulmonary hypertension and exercise training: a synopsis on the more recent evidences.

Leggio M, Fusco A, Armeni M, D'Emidio S, Severi P, Calvaruso S, Limongelli G, Sgorbini L, Bendini MG, Mazza A.

Ann Med. 2018 May;50(3):226-233. doi: 10.1080/07853890.2018.1432887. Epub 2018 Jan 30. Review.

PMID:
29363985
46.

Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: the importance of clinical context.

Quarta G, Aquaro GD, Pedrotti P, Pontone G, Dellegrottaglie S, Iacovoni A, Brambilla P, Pradella S, Todiere G, Rigo F, Bucciarelli-Ducci C, Limongelli G, Roghi A, Olivotto I.

Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):601-610. doi: 10.1093/ehjci/jex323. Review.

PMID:
29309572
47.

Management of Bradyarrhythmias in Heart Failure: A Tailored Approach.

Masarone D, Ammendola E, Rago A, Gravino R, Salerno G, Rubino M, Marrazzo T, Molino A, Calabrò P, Pacileo G, Limongelli G.

Adv Exp Med Biol. 2018;1067:255-269. doi: 10.1007/5584_2017_136. Erratum in: Adv Exp Med Biol. 2018 Apr 11;:.

PMID:
29280096
48.

Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience.

Gragnano F, Natale F, Concilio C, Fimiani F, Cesaro A, Sperlongano S, Crisci M, Limongelli G, Calabrò R, Russo M, Golia E, Calabrò P.

J Cardiovasc Med (Hagerstown). 2018 Feb;19(2):75-77. doi: 10.2459/JCM.0000000000000611. No abstract available.

PMID:
29251697
49.

A child with Myhre syndrome presenting with corectopia and tetralogy of Fallot.

Alagia M, Cappuccio G, Pinelli M, Torella A, Brunetti-Pierri R, Simonelli F, Limongelli G, Oppido G, Nigro V, Brunetti-Pierri N; TUDP.

Am J Med Genet A. 2018 Feb;176(2):426-430. doi: 10.1002/ajmg.a.38560. Epub 2017 Dec 12.

50.

Contemporary genetic testing in inherited cardiac disease: tools, ethical issues, and clinical applications.

Girolami F, Frisso G, Benelli M, Crotti L, Iascone M, Mango R, Mazzaccara C, Pilichou K, Arbustini E, Tomberli B, Limongelli G, Basso C, Olivotto I.

J Cardiovasc Med (Hagerstown). 2018 Jan;19(1):1-11. doi: 10.2459/JCM.0000000000000589.

Supplemental Content

Loading ...
Support Center